NA22598, a Novel Antitumor Compound, Reduces Cyclin D1 Levels, Arrests Cell Cycle at G1 Phase, and Inhibits Anchorage-Independent Growth of Human Tumor Cells

Author: Kawada M.   Kuwahara A.   Nishikiori T.   Mizuno S.   Uehara Y.  

Publisher: Elsevier

ISSN: 0014-4827

Source: Experimental Cell Research, Vol.249, Iss.2, 1999-06, pp. : 240-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content